DPP4 and diabetes mellitus: Currently, drug therapy is the main treatment for DM, including the dipeptidyl peptidase-4 inhibitor, sitagliptin, which is approved in more than 130 countries worldwide as monotherapy and in combination with other antihyperglycemic drugs for the treatment of adult patients with T2D.